Synovis Life Technologies (SYNO) Reports Mixed Q4 Earnings
Synovis Life Technologies, Inc. (Nasdaq: SYNO) reports Q4 EPS of $0.15, 1 cent better than the analyst estimate of $0.14. Revenue for the quarter was $12.7 million, versus the consensus of $13.79 million.
Synovis Life Technologies, Inc., a medical device company, engages in the development, manufacture, marketing, and sale of products for the surgical treatment of disease.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
